245 related articles for article (PubMed ID: 23249388)
1. Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells.
Majumdar G; Adris P; Bhargava N; Chen H; Raghow R
BMC Genomics; 2012 Dec; 13():709. PubMed ID: 23249388
[TBL] [Abstract][Full Text] [Related]
2. Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.
Majumdar G; Rooney RJ; Johnson IM; Raghow R
Physiol Genomics; 2011 Dec; 43(24):1319-33. PubMed ID: 21954451
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide.
Majumdar G; Johnson IM; Kale S; Raghow R
Mol Cell Biochem; 2008 May; 312(1-2):47-60. PubMed ID: 18292970
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes.
Majumdar G; Raghow R
Mol Cell Biochem; 2016 Apr; 415(1-2):39-49. PubMed ID: 26946427
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
6. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
Mazzio EA; Soliman KF
Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
[TBL] [Abstract][Full Text] [Related]
7. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells.
Kumar D; Sarma P; Bhadra MP; Tangutur AD
Anticancer Agents Med Chem; 2019; 19(6):750-759. PubMed ID: 30621566
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
Chung CL; Sheu JR; Chen WL; Chou YC; Hsiao CJ; Hsiao SH; Hsu MJ; Cheng YW; Hsiao G
Am J Respir Cell Mol Biol; 2012 Apr; 46(4):437-45. PubMed ID: 22033265
[TBL] [Abstract][Full Text] [Related]
10. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
11. Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.
Yang G; Tian J; Feng C; Zhao LL; Liu Z; Zhu J
Cell Transplant; 2012; 21(5):985-96. PubMed ID: 21944777
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.
Zhu J; Gu J; Ma J; Xu Z; Tao H
J BUON; 2015; 20(1):269-74. PubMed ID: 25778327
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HDAC Enzymes Contributes to Differential Expression of Pro-Inflammatory Proteins in the TLR-4 Signaling Cascade.
Weiss U; Möller M; Husseini SA; Manderscheid C; Häusler J; Geisslinger G; Niederberger E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255670
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
Kortenhorst MS; Wissing MD; Rodríguez R; Kachhap SK; Jans JJ; Van der Groep P; Verheul HM; Gupta A; Aiyetan PO; van der Wall E; Carducci MA; Van Diest PJ; Marchionni L
Epigenetics; 2013 Sep; 8(9):907-20. PubMed ID: 23880963
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
Feng Q; Su Z; Song S; Χu H; Zhang B; Yi L; Tian M; Wang H
Int J Mol Med; 2016 Sep; 38(3):812-22. PubMed ID: 27460781
[TBL] [Abstract][Full Text] [Related]
17. [Effect of trichostatin A on the osteogenic differentiation potential of periodontal ligament stem cells in inflammatory microenvironment induced by tumor necrosis factor-α stimulation].
Wang H; Chen Q; Liu WJ; Yang ZH; Li D; Jin F
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Apr; 51(4):235-41. PubMed ID: 27117217
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
Qiu X; Rong X; Yang J; Lu Y
BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes.
Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H
Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.
Zhang LX; Zhao Y; Cheng G; Guo TL; Chin YE; Liu PY; Zhao TC
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2154-63. PubMed ID: 20382965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
